These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9653895)

  • 21. Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities.
    Waterman IJ; Zammit VA
    Diabetes; 2002 Jun; 51(6):1708-13. PubMed ID: 12031956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.
    Roglans N; Sanguino E; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):232-9. PubMed ID: 12065722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
    Funatsu T; Kakuta H; Takasu T; Miyata K
    Eur J Pharmacol; 2002 Nov; 455(2-3):161-7. PubMed ID: 12445582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia.
    Amano Y; Nishimoto T; Tozawa Ri; Ishikawa E; Imura Y; Sugiyama Y
    Eur J Pharmacol; 2003 Apr; 466(1-2):155-61. PubMed ID: 12679152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures.
    Funck VR; de Oliveira CV; Pereira LM; Rambo LM; Ribeiro LR; Royes LF; Ferreira J; Guerra GP; Furian AF; Oliveira MS; Mallmann CA; de Mello CF; Oliveira MS
    Epilepsia; 2011 Nov; 52(11):2094-104. PubMed ID: 21906051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit.
    Rashid S; Uffelman KD; Barrett PH; Lewis GF
    Circulation; 2002 Dec; 106(23):2955-60. PubMed ID: 12460878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the mechanism of the hypolipidemic effect of sulfur-substituted hexadecanedioic acid (3-thiadicarboxylic acid) in normolipidemic rats.
    Skorve J; al-Shurbaji A; Asiedu D; Björkhem I; Berglund L; Berge RK
    J Lipid Res; 1993 Jul; 34(7):1177-85. PubMed ID: 8371065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological investigation of bezafibrate, a hypolipidemic agent (2). Mechanism of the hypolipidemic action of bezafibrate in rats].
    Kusama H; Nishiyama M; Matsubara Y; Ikeda S
    Nihon Yakurigaku Zasshi; 1988 Sep; 92(3):181-91. PubMed ID: 2907502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K; Vaziri ND
    Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells.
    Scharnagl H; Schinker R; Gierens H; Nauck M; Wieland H; März W
    Biochem Pharmacol; 2001 Dec; 62(11):1545-55. PubMed ID: 11728391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.
    Cibickova L; Hyspler R; Micuda S; Cibicek N; Zivna H; Jun D; Ticha A; Brcakova E; Palicka V
    Steroids; 2009 Jan; 74(1):13-9. PubMed ID: 18817797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia.
    Aoki T; Yamazaki H; Suzuki H; Tamaki T; Sato F; Kitahara M; Saito Y
    Arzneimittelforschung; 2001; 51(3):197-203. PubMed ID: 11304935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
    Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
    Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids.
    Bok SH; Lee SH; Park YB; Bae KH; Son KH; Jeong TS; Choi MS
    J Nutr; 1999 Jun; 129(6):1182-5. PubMed ID: 10356084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypolipidemic effect of dietary diacylglycerol oil in Sprague-Dawley rats fed a normal diet.
    Kim HJ; Lee KT; Lee MK; Jeon SM; Jung UJ; Cho YY; Choi MS
    J Med Food; 2007 Mar; 10(1):60-6. PubMed ID: 17472468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
    Vaziri ND; Sato T; Liang K
    Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the mechanism of regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and of acyl coenzyme A:cholesterol acyltransferase by dietary fat.
    Mitropoulos KA; Venkatesan S; Balasubramaniam S
    Biochim Biophys Acta; 1980 Aug; 619(2):247-57. PubMed ID: 7407210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effects of active components of Polygonum Multiflorum Radix on enzymes involved in the lipid metabolism.
    Wang W; He Y; Lin P; Li Y; Sun R; Gu W; Yu J; Zhao R
    J Ethnopharmacol; 2014 May; 153(3):763-70. PubMed ID: 24680992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
    Vaziri ND; Liang K; Azad H
    J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.